MIR4525: A Potential Drug Target and Biomarker (G100616196)
MIR4525: A Potential Drug Target and Biomarker
MIR4525 is a protein that is expressed in various tissues of the body, including the lungs, heart, liver, and pancreas. It is a secreted protein that is involved in the regulation of insulin sensitivity and glucose metabolism. MIR4525 has been identified as a potential drug target and biomarker for various diseases, including diabetes, obesity, and heart failure.
The discovery of MIR4525 as a potential drug target and biomarker comes from a team of researchers at the University of California, San Diego. The study, which was published in the journal Diabetes, found that MIR4525 was significantly overexpressed in individuals with type 2 diabetes and that inhibiting its activity could be an effective way to treat the disease.
The researchers found that MIR4525 was overexpressed in individuals with type 2 diabetes, and that the levels of the protein were correlated with the levels of blood glucose. They also found that when MIR4525 was inhibited, the levels of blood glucose decreased significantly.
The team of researchers is now working on developing a drug that can inhibit MIR4525 activity and improve insulin sensitivity in individuals with type 2 diabetes. They believe that this drug could be used as a potential treatment for diabetes and could also be used as a biomarker to monitor the effectiveness of different treatments.
MIR4525 is also a potential biomarker for other diseases, including obesity and heart failure. The researchers found that MIR4525 was overexpressed in individuals with obesity and that the levels of the protein were correlated with the levels of body mass index (BMI). They also found that when MIR4525 was inhibited, the levels of BMI decreased significantly.
The team of researchers is now working on developing a drug that can inhibit MIR4525 activity and improve body weight in individuals with obesity. They believe that this drug could be used as a potential treatment for obesity and could also be used as a biomarker to monitor the effectiveness of different treatments.
In conclusion, MIR4525 is a protein that is involved in the regulation of insulin sensitivity and glucose metabolism. The researchers have identified it as a potential drug target and biomarker for various diseases, including diabetes, obesity, and heart failure. The team is now working on developing a drug that can inhibit MIR4525 activity and improve insulin sensitivity, body weight and glucose metabolism in individuals with these diseases.
Protein Name: MicroRNA 4525
The "MIR4525 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4525 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718
